Journalartikel
Autorenliste: Klimek, Ludger; Brehler, Randolf; Hamelmann, Eckard; Kopp, Matthias; Ring, Johannes; Treudler, Regina; Jakob, Thilo; Worm, Margitta; Pfaar, Oliver
Jahr der Veröffentlichung: 2019
Seiten: 31-46
Zeitschrift: Allergo-Journal
Bandnummer: 28
Heftnummer: 4
ISSN: 0941-8849
eISSN: 2195-6405
DOI Link: https://doi.org/10.1007/s15007-019-1847-4
Verlag: SPRINGER HEIDELBERG
Zitierstile
Harvard-Zitierstil: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., et al. (2019) Development of subcutaneous Allergen Immunotherapy (Part 2): preventive Aspects of SCIT and Innovations, Allergo-Journal, 28(4), pp. 31-46. https://doi.org/10.1007/s15007-019-1847-4
APA-Zitierstil: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019). Development of subcutaneous Allergen Immunotherapy (Part 2): preventive Aspects of SCIT and Innovations. Allergo-Journal. 28(4), 31-46. https://doi.org/10.1007/s15007-019-1847-4
Schlagwörter
DOUBLE-BLIND; GRASS-POLLEN IMMUNOTHERAPY; HOUSE-DUST MITE; L-TYROSINE; MONOPHOSPHORYL-LIPID-A; RECOMBINANT ALLERGENS; SEASONAL RHINOCONJUNCTIVITIS
